Observational studyOpen heart2026
Development of a heart failure with preserved ejection fraction risk prediction score in primary care settings with a high HIV prevalence.
Observational study in Open heart, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundAntiretroviral therapy (ART)-treated people with HIV (PWH) have increased risk of heart failure with preserved ejection fraction (HFpEF). The diagnosis of HFpEF relies on cardiac imaging and expertise and is challenging in primary care settings. Further, existing risk prediction tools do not account for HIV-related risk. We developed a practical HFpEF risk prediction tool using data from the Prevalence and Phenotype of HIV-HFpEF in South Africa, a cross-sectional observational study that enrolled 1508 adults aged ≥40 years (1008 PWH on ART ≥1 year and 500 people without HIV (PWoH)) at a primary care clinic in South Africa.
methodsWe used four logistic regression models for HFpEF risk, including demographics, clinical factors, B-type natriuretic peptide (BNP) and ECG abnormalities. We compared the models' area under the receiver operating characteristic curve (AUC) with a random forest classifier, translated the final model into a nomogram-based risk score and evaluated its discrimination and calibration through bootstrap internal validation.
resultsThe median age was 48 years, 77% female, 42% obese, 38% had hypertension and 7.8% met HFpEF criteria (118 participants; 85 (8.4%) among PWH and 33 (6.6%) among PWoH). Two logistic regression models outperformed the random forest classifier. The model that was used for the nomogram included age, sex, HIV status, smoking, hypertension, body mass index and BNP and showed good discrimination (overfitting-corrected AUC 0.77) with good calibration.
conclusionsThe nomogram-based score, developed using routine clinical information and point-of-care BNP, is practical, accessible and may support screening and identification of individuals at high HFpEF risk for targeted referral for diagnosis and care in a sub-Saharan African primary care setting with a high HIV prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.